October 27, 2025

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 36% Potential Upside with Solid Analyst Ratings

Investors seeking opportunities within the healthcare sector’s medical instruments and supplies industry may find AptarGroup, Inc. (NYSE: ATR) an intriguing prospect. With a market capitalization of $8.49 billion, this U.S.-based..

Guardant Health, Inc. (GH) Stock Analysis: Navigating the Diagnostic Frontier with 30.9% Revenue Growth

Guardant Health, Inc. (NASDAQ: GH), a key player in the diagnostics and research industry, has been making waves with its innovative contributions to precision oncology. With a market capitalization of..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a Challenging Path with -35.85% Potential Downside

Oscar Health, Inc. (NYSE: OSCR) continues to capture the attention of investors navigating the volatile healthcare sector. As a healthcare technology company based in New York, Oscar Health is known..

Grifols, S.A. (GRFS) Stock Analysis: Unpacking a 28.81% Potential Upside for Savvy Investors

Investors keen on tapping into the healthcare sector’s promising growth may find Grifols, S.A. (GRFS) an intriguing prospect. With its roots firmly planted in the drug manufacturing industry, this Spanish..

TransMedics Group, Inc. (TMDX) Stock Analysis: A Robust Growth Trajectory with 8.52% Potential Upside

TransMedics Group, Inc. (NASDAQ: TMDX) is making waves in the healthcare sector with its innovative approach to organ transplant therapy. The company’s unique Organ Care System (OCS) is setting new..

Corcept Therapeutics (CORT) Stock Analysis: Exploring a Potential 86.50% Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT) has captured the attention of investors with its promising growth trajectory within the biotechnology sector. Headquartered in Redwood City, California, Corcept specializes in the discovery..

Glaukos Corporation (GKOS) Stock Analysis: Navigating a 60% Potential Upside in the Medical Devices Sector

In the rapidly evolving medical devices sector, Glaukos Corporation (NYSE: GKOS) stands out as a formidable player specializing in ophthalmic pharmaceuticals and medical technologies. With a market capitalization of $4.28..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 19% Potential Upside in the Medical Devices Sector

Investors looking for opportunities in the healthcare sector may want to keep an eye on Bruker Corporation (NASDAQ: BRKR). With a market capitalization of $5.92 billion, this Massachusetts-based medical device..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Strong Buy Ratings Signal Robust Growth Potential

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is drawing significant investor attention in the biotechnology sector, primarily due to its innovative focus on rare neuroendocrine diseases. With a market capitalization of $7.34..

Walgreens Boots Alliance, Inc. (WBA) Stock Analysis: Exploring an 8.35% Dividend Yield Amidst Challenging Metrics

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) stands as a formidable player in the healthcare and pharmaceutical retail sector, with a sprawling global presence that spans the United States, Europe, and..

Tenet Healthcare Corporation (THC) Stock Analysis: Strong Buy Ratings and Promising Growth Potential

Tenet Healthcare Corporation (NYSE: THC), a major player in the United States healthcare sector, is capturing investor attention with its robust market performance and promising growth potential. Operating across two..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Unveiling a 37.59% Potential Upside in CNS Therapy Innovations

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company rooted in the healthcare sector, is making waves in the biotechnology industry with its innovative therapies targeting central nervous system (CNS) disorders...

Integer Holdings Corporation (ITGR) Stock Report: Navigating a 17.95% Upside Potential

Integer Holdings Corporation (NYSE: ITGR) is a key player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $2.55 billion, the company is a..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Unveiling a 14% Upside Potential

Krystal Biotech, Inc. (NASDAQ: KRYS) continues to draw attention in the competitive biotechnology sector for its innovative genetic medicines targeting diseases with significant unmet medical needs. With a current market..

Viatris Inc. (VTRS) Stock Analysis: Exploring a 15.94% Potential Upside Amidst Dividend Strength and Challenges

Viatris Inc. (NASDAQ: VTRS) presents an intriguing opportunity for investors with its potential upside of 15.94%, a robust dividend yield of 4.64%, and a portfolio that spans a broad spectrum..

Johnson & Johnson (JNJ) Stock Analysis: Evaluating Its 4.24% Potential Upside and Robust Dividend Yield

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to capture the attention of investors with its expansive portfolio and substantial market presence. With a market capitalization..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 27% Potential Upside

For investors eyeing the healthcare sector, Takeda Pharmaceutical Company Limited (NYSE: TAK) presents an intriguing opportunity. With a market capitalization of $44.45 billion, this Tokyo-based pharmaceutical powerhouse is a cornerstone..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a 79.51% Potential Upside in the Biotechnology Sector

In the dynamic landscape of the biotechnology sector, ADMA Biologics Inc (NASDAQ: ADMA) emerges as a compelling player with a substantial market capitalization of $3.62 billion. Headquartered in Ramsey, New..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Unraveling a 40% Upside Potential in the Biotech Arena

Avidity Biosciences, Inc. (NASDAQ: RNA) is at the forefront of innovation in the biotechnology sector, leveraging its distinctive RNA therapeutic platform to address diseases previously deemed untreatable. Headquartered in San..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Unveiling Growth Potential Amidst Biotech Challenges

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a notable player in the healthcare sector, operating within the biotechnology industry. With a market capitalisation of $2.39 billion, this U.S.-based biopharmaceutical company..

Search

Funds

October 27, 2025

Search

Funds

October 27, 2025

FTSE 100

Funds